These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8280614)

  • 1. A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.
    Liu JM; Auerbach AD; Anderson SM; Green SW; Young NS
    Br J Haematol; 1993 Oct; 85(2):406-8. PubMed ID: 8280614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine superoxide dismutase in Fanconi anaemia. Therapeutic trial in two patients.
    Izakovic V; Strbáková E; Kaiserová E; Krizan P
    Hum Genet; 1985; 70(2):181-2. PubMed ID: 3891581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population.
    Korgaonkar S; Ghosh K; Vundinti BR
    Hematology; 2010 Feb; 15(1):58-62. PubMed ID: 20132664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors.
    Suzuki NM; Niwa A; Yabe M; Hira A; Okada C; Amano N; Watanabe A; Watanabe K; Heike T; Takata M; Nakahata T; Saito MK
    Stem Cells Transl Med; 2015 Apr; 4(4):333-8. PubMed ID: 25762002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal breakage study in children suspected with Fanconi anemia in the Indian population.
    Korgaonkar S; Ghosh K; Jijina F; Vundinti BR
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):606-10. PubMed ID: 20881871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling.
    Zhang QS; Benedetti E; Deater M; Schubert K; Major A; Pelz C; Impey S; Marquez-Loza L; Rathbun RK; Kato S; Bagby GC; Grompe M
    Stem Cell Reports; 2015 Jan; 4(1):90-102. PubMed ID: 25434823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fanconi anaemia/BRCA pathway.
    D'Andrea AD; Grompe M
    Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
    Liu JM; Young NS; Walsh CE; Cottler-Fox M; Carter C; Dunbar C; Barrett AJ; Emmons R
    Hum Gene Ther; 1997 Sep; 8(14):1715-30. PubMed ID: 9322874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p.
    Whitney M; Thayer M; Reifsteck C; Olson S; Smith L; Jakobs PM; Leach R; Naylor S; Joenje H; Grompe M
    Nat Genet; 1995 Nov; 11(3):341-3. PubMed ID: 7581463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term bone marrow culture in Fanconi's anaemia.
    Stark R; Thierry D; Richard P; Gluckman E
    Br J Haematol; 1993 Apr; 83(4):554-9. PubMed ID: 8518173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of Fanconi's anaemia.
    Dokal I
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):407-25. PubMed ID: 11030042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
    Venkatraj VS; Gaidano G; Auerbach AD
    Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia.
    Li X; Leteurtre F; Rocha V; Guardiola P; Berger R; Daniel MT; Noguera MH; Maarek O; Roux GL; de la Salmonière P; Richard P; Gluckman E
    Br J Haematol; 2003 Mar; 120(5):836-45. PubMed ID: 12614219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Fanconi anaemia in phenotypically normal aplastic anaemia patients in West Bengal.
    Dutta A; De R; Dolai TK; Pal P; Ghosh S; Mitra PK; Halder A
    Hematology; 2018 Aug; 23(7):405-412. PubMed ID: 29307285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chromosome abnormalities in bone marrow cells and peripheral lymphocytes in a patient with Fanconi's anemia].
    Margiotta G; Barbata G; Carbone P; Granata G; Caronia F
    Minerva Med; 1981 Sep; 72(35):2361-5. PubMed ID: 7279258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased superoxide dismutase activity of erythrocytes and leukocytes in Fanconi's anemia.
    Yoshimitsu K; Kobayashi Y; Usui T
    Acta Haematol; 1984; 72(3):208-10. PubMed ID: 6438987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amifostine protection against mitomycin-induced chromosomal breakage in fanconi anaemia lymphocytes.
    Camelo RM; Kehdy FS; Salas CE; Lopes MT
    Molecules; 2008 Aug; 13(8):1759-72. PubMed ID: 18794784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in biology and therapy of aplastic anemia and other conditions of bone marrow failure].
    Robak T
    Postepy Hig Med Dosw; 1992; 46(1):21-51. PubMed ID: 1641375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.